Stocks in Action USA: Moderna, Ross Stores, Coinbase

The stock of Moderna reacts with a price jump to the resolution of a long-standing patent dispute surrounding Covid-19 vaccines. The US biotech company agrees with Arbutus Biopharma and Genevant Sciences on a settlement payment of initially $950 million, due in the third quarter. Should an ongoing appeal in a US federal court fail, an additional $1.3 billion would be due within 90 days. In return, all future licensing and royalty claims on the disputed lipid nanoparticle (LNP) technology – including for future vaccines – will be waived. Moderna...